Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A E Izu

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Vaccine|August 7, 1999
A randomized, controlled study in adults of the immunogenicity of a novel hepatitis B vaccine containing MF59 adjuvantT C Heineman, M L Clements-Mann, G A Poland, et al.
The Journal of Infectious Diseases|October 9, 1999
Effects of antigen dose and immunization regimens on antibody responses to a cytomegalovirus glycoprotein B subunit vaccineS E Frey, C Harrison, R F Pass, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1991
Phase 1 study of recombinant human CD4-immunoglobulin G therapy of patients with AIDS and AIDS-related complexT L Hodges, J O Kahn, L D Kaplan, et al.
Annals of Internal Medicine|February 15, 1990
The safety and pharmacokinetics of recombinant soluble CD4 (rCD4) in subjects with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. A phase 1 studyJ O Kahn, J D Allan, T L Hodges, et al.
Journal of the American Academy of Dermatology|February 1, 1993
Recombinant interferon gamma therapy for atopic dermatitisJ M Hanifin, L C Schneider, D Y Leung, et al.
Vaccine|August 26, 1999
An acellular pertussis vaccine in healthy adults: safety and immunogenicity. Pennridge Pediatric AssociatesE P Rothstein, E L Anderson, M D Decker, et al.
JAMA|August 4, 1999
Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study GroupL Corey, A G Langenberg, R Ashley, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Vaccine|August 7, 1999
A randomized, controlled study in adults of the immunogenicity of a novel hepatitis B vaccine containing MF59 adjuvantT C Heineman, M L Clements-Mann, G A Poland, et al.
The Journal of Infectious Diseases|October 9, 1999
Effects of antigen dose and immunization regimens on antibody responses to a cytomegalovirus glycoprotein B subunit vaccineS E Frey, C Harrison, R F Pass, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1991
Phase 1 study of recombinant human CD4-immunoglobulin G therapy of patients with AIDS and AIDS-related complexT L Hodges, J O Kahn, L D Kaplan, et al.
Annals of Internal Medicine|February 15, 1990
The safety and pharmacokinetics of recombinant soluble CD4 (rCD4) in subjects with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. A phase 1 studyJ O Kahn, J D Allan, T L Hodges, et al.
Journal of the American Academy of Dermatology|February 1, 1993
Recombinant interferon gamma therapy for atopic dermatitisJ M Hanifin, L C Schneider, D Y Leung, et al.
Vaccine|August 26, 1999
An acellular pertussis vaccine in healthy adults: safety and immunogenicity. Pennridge Pediatric AssociatesE P Rothstein, E L Anderson, M D Decker, et al.
JAMA|August 4, 1999
Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study GroupL Corey, A G Langenberg, R Ashley, et al.
Pageof 2